KR950704257A - 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors) - Google Patents
매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)Info
- Publication number
- KR950704257A KR950704257A KR1019940704126A KR19940704126A KR950704257A KR 950704257 A KR950704257 A KR 950704257A KR 1019940704126 A KR1019940704126 A KR 1019940704126A KR 19940704126 A KR19940704126 A KR 19940704126A KR 950704257 A KR950704257 A KR 950704257A
- Authority
- KR
- South Korea
- Prior art keywords
- matrix metalloproteinases
- carbostyril derivatives
- metalloproteinases inhibitors
- inhibitors
- carbostyril
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5826493 | 1993-03-18 | ||
| JP25687393 | 1993-10-14 | ||
| PCT/JP1994/000434 WO1994021612A1 (en) | 1993-03-18 | 1994-03-17 | Carbostyril derivatives as matrix metalloproteinases inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950704257A true KR950704257A (ko) | 1995-11-17 |
Family
ID=26399315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940704126A Withdrawn KR950704257A (ko) | 1993-03-18 | 1994-11-18 | 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors) |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0641323A1 (enExample) |
| KR (1) | KR950704257A (enExample) |
| CN (1) | CN1105799A (enExample) |
| AU (1) | AU672888B2 (enExample) |
| CA (1) | CA2136108A1 (enExample) |
| TW (1) | TW290541B (enExample) |
| WO (1) | WO1994021612A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
| US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
| US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| WO1997019053A1 (en) | 1995-11-23 | 1997-05-29 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
| AU1529897A (en) * | 1996-01-02 | 1997-07-28 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| KR20000005175A (ko) * | 1996-04-04 | 2000-01-25 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 테트라하이드로-베타-카르볼린 유도체의 항전이제로서의 용도 |
| JP4238334B2 (ja) | 1996-09-10 | 2009-03-18 | ヴァーナリス （アールアンドディー） リミテッド | 細胞増殖抑制性ヒドロキサム酸誘導体 |
| US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
| US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
| US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
| US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
| DE60219630T2 (de) | 2001-06-15 | 2007-12-27 | Vicuron Pharmaceuticals, Inc., Fremont | Bicyclische pyrrolidinverbindungen |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| JP4394686B2 (ja) | 2003-07-30 | 2010-01-06 | 大塚製薬株式会社 | 唾液分泌促進用医薬組成物およびその使用 |
| CN108285469B (zh) * | 2018-03-15 | 2020-07-24 | 遵义医学院 | 一种抗菌类喹诺酮衍生物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB9107368D0 (en) * | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
-
1994
- 1994-03-17 WO PCT/JP1994/000434 patent/WO1994021612A1/en not_active Ceased
- 1994-03-17 TW TW083102314A patent/TW290541B/zh active
- 1994-03-17 EP EP94910035A patent/EP0641323A1/en not_active Ceased
- 1994-03-17 CA CA002136108A patent/CA2136108A1/en not_active Abandoned
- 1994-03-17 CN CN94190137A patent/CN1105799A/zh active Pending
- 1994-03-17 AU AU62637/94A patent/AU672888B2/en not_active Ceased
- 1994-11-18 KR KR1019940704126A patent/KR950704257A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0641323A1 (en) | 1995-03-08 |
| AU672888B2 (en) | 1996-10-17 |
| TW290541B (enExample) | 1996-11-11 |
| AU6263794A (en) | 1994-10-11 |
| CA2136108A1 (en) | 1994-09-29 |
| CN1105799A (zh) | 1995-07-26 |
| WO1994021612A1 (en) | 1994-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950704257A (ko) | 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors) | |
| FI961857A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| NO942064D0 (no) | yminhibitorer | |
| FI972160A7 (fi) | Matriisimetalloproteaasi-inhibiittorit | |
| FI944804L (fi) | Pyrimidinyyliasetamideja elastaasin estäjinä | |
| ATE222240T1 (de) | Hiv - protease inhibitoren | |
| NO962269D0 (no) | Enzyminhibitorer | |
| FI904101A7 (fi) | 17B-asyyli-4-atsa-5a-androst-1-en-3-en-3-oneja 5a-reduktaasi-inhibiittoreina | |
| FI956119L (fi) | Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina | |
| FI933277A7 (fi) | Amiinidioli proteaasi-inhibiittorit | |
| FI942423A7 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
| FI962022L (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| FI960482A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| FI940573L (fi) | Geneseriinin johdannaiset koliiniestraasin inhibiittoreina | |
| FI945674A7 (fi) | Substituoidut 2beta-morfoliini-androstaanijohdannaiset | |
| FI962021L (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| KR960703888A (ko) | 이소플라본 유도체 (isoflavone derivatives) | |
| EE9900180A (et) | Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena | |
| FI101796B1 (fi) | Uusia -glukosidaasi-inhibiittoreita | |
| ATE205822T1 (de) | Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren | |
| FI960730A7 (fi) | Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina | |
| NO962015D0 (no) | Pyron-derivater som protease-inhibitorer og antivirus-midler | |
| FI941259L (fi) | Uudet alfa-mannosidaasiestäjät | |
| FI962020L (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| DE69431454D1 (de) | Amylase Inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19941118 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |